Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIXIU
4526
Bitcoin Infrastructure Acquisition Corp Unit
BIXIU
| $4.19M | ﹤0.01% |
+420,795
| New | +$4.21M |
|
4527
CALL
Array Technologies
ARRY
$855M
| $4.19M | ﹤0.01% |
454,200
+117,200
| +35% | +$1.01M |
|
|
RNAM
4528
CALL
DELISTED
Avidity Biosciences
RNAM
| $4.18M | ﹤0.01% |
58,000
-38,900
| -40% | -$2.51M |
|
4529
PUT
IMAX
IMAX
$2.66B
| $4.18M | ﹤0.01% |
113,000
+59,500
| +111% | +$2.07M |
|
4530
PUT
ICICI Bank
IBN
$108B
| $4.17M | ﹤0.01% |
140,100
+45,100
| +47% | +$1.38M |
|
4531
CALL
Atmos Energy
ATO
$28.8B
| $4.17M | ﹤0.01% |
24,900
-9,800
| -28% | -$1.69M |
|
4532
CALL
Build-A-Bear
BBW
$462M
| $4.17M | ﹤0.01% |
68,100
-4,700
| -6% | -$256K |
|
|
HAPN
4533
PUT
Happen Inc
HAPN
$2.24B
| $4.17M | ﹤0.01% |
220,200
+126,600
| +135% | +$2.24M |
|
4534
CALL
Bruker
BRKR
$8.14B
| $4.17M | ﹤0.01% |
88,500
-35,800
| -29% | -$1.51M |
|
4535
PUT
Credit Acceptance
CACC
$6.08B
| $4.17M | ﹤0.01% |
9,400
+800
| +9% | +$371K |
|
4536
Aurora
AUR
$13.8B
| $4.17M | ﹤0.01% |
1,085,236
-908,584
| -46% | -$4.16M |
|
4537
Amylyx Pharmaceuticals
AMLX
$2.54B
| $4.17M | ﹤0.01% |
344,968
+110,295
| +47% | +$1.5M |
|
4538
PUT
PENN Entertainment
PENN
$2.7B
| $4.17M | ﹤0.01% |
282,500
-2,300
| -0.8% | -$35.9K |
|
4539
RPC Inc
RES
$1.3B
| $4.17M | ﹤0.01% |
765,899
-170,500
| -18% | -$886K |
|
4540
CALL
Jazz Pharmaceuticals
JAZZ
$16.7B
| $4.17M | ﹤0.01% |
24,500
-16,200
| -40% | -$2.48M |
|
4541
Ferguson
FERG
$49.8B
| $4.16M | ﹤0.01% |
18,701
-826,028
| -98% | -$197M |
|
|
PPTA
4542
CALL
Perpetua Resources
PPTA
$3.09B
| $4.16M | ﹤0.01% |
171,800
+37,300
| +28% | +$918K |
|
4543
CALL
Boston Beer
SAM
$1.92B
| $4.16M | ﹤0.01% |
21,300
-5,500
| -21% | -$1.13M |
|
4544
CALL
CACI
CACI
$14.2B
| $4.16M | ﹤0.01% |
7,800
-14,600
| -65% | -$8.25M |
|
4545
Dycom Industries
DY
$12.3B
| $4.16M | ﹤0.01% |
12,297
-78,657
| -86% | -$24.8M |
|
|
CCCX
4546
PUT
DELISTED
Churchill Capital Corp X
CCCX
| $4.15M | ﹤0.01% |
266,100
+224,300
| +537% | +$3.77M |
|
4547
CALL
Trimble
TRMB
$13.9B
| $4.14M | ﹤0.01% |
52,900
-30,400
| -36% | -$2.42M |
|
4548
PUT
Keros Therapeutics
KROS
$221M
| $4.14M | ﹤0.01% |
203,400
+156,600
| +335% | +$2.75M |
|
4549
CALL
Gulfport Energy Corp
GPOR
$2.88B
| $4.14M | ﹤0.01% |
19,900
+2,500
| +14% | +$498K |
|
4550
PUT
Bio-Techne
TECH
$11.3B
| $4.13M | ﹤0.01% |
70,300
+15,400
| +28% | +$936K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.